Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
  • Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a company name.

Moberg Pharma AB

Headquarters: Bromma, Sweden
Year Founded: 2006
Status: Public
Industry Sector: HealthTechnology
CEO: Anna Ljung
Number Of Employees: 9
Enterprise Value: $8,716,009
PE Ratio: -1.39
Exchange/Ticker 1: SSE:MOB
Exchange/Ticker 2: N/A
Latest Market Cap: $37,312,640

BioCentury | Apr 8, 2019
Company News

Management tracks: WuXi AppTec, Kymab, Acceleron

BioCentury | Oct 10, 2016
Clinical News

MOB-015: Phase III started

BioCentury | Oct 10, 2016
Clinical News

MOB-015: Phase III started

BioCentury | Jul 11, 2016
Financial News

Moberg Pharma completes bond

BioCentury | Feb 1, 2016
Financial News

Moberg Pharma completes bond

BioCentury | Jan 18, 2016
Clinical News

Bupivacaine: Phase II data

BioCentury | Jan 4, 2016
Company News

Colep, Moberg Pharma deal

BioCentury | Nov 17, 2014
Clinical News

Bupivacaine: Phase II started

Items per page:
1 - 10 of 18